Trending News

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

Supreme Court Eliminates Heightened Discrimination Standard Under Title VII

Cleaning the Cupboard—Six More Decisions in One Day, and a Largely Harmonious Court - SCOTUS Today

U.S. Supreme Court Holds Majority-Group Plaintiffs Are Not Subject to a Heightened Evidentiary Standard Under Title VII

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
Posted On Friday, July 18, 2025
EURneffy® (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
Posted On Friday, July 18, 2025
Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval
Posted On Friday, July 18, 2025
Senti Bio Appoints Entrepreneurial Leader and Investor, Bryan Baum, to Board of Directors
Posted On Friday, July 18, 2025
Generation Bio Announces 1-for-10 Reverse Stock Split
Posted On Friday, July 18, 2025
Lexicon to Present Patient-reported Data on Diabetic Peripheral Neuropathic Pain (DPNP) at the 7th Annual Meeting of the American Society of Pain and Neuroscience (ASPN 2025)
Posted On Friday, July 18, 2025
Aardvark Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
Posted On Friday, July 18, 2025
FOXO TECHNOLOGIES INC. ANNOUNCES INTENTION TO SPIN OFF EPIGENETICS SUBSIDIARY
Posted On Friday, July 18, 2025
Ocugen, Inc. Announces First Patient Dosed in Phase 2/3 GARDian3 Pivotal Confirmatory Trial for OCU410ST—Novel Modifier Gene Therapy Candidate for Stargardt Disease
Posted On Friday, July 18, 2025
Trogenix Bolsters Clinical Research Team with Appointment of Atif Abbas as Chief Medical Officer and Carolyn Edwards as Vice President, Research & Development
Posted On Friday, July 18, 2025
SAPU Bioscience Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients
Posted On Thursday, July 17, 2025
FOXO TECHNOLOGIES INC. ANNOUNCES REVERSE STOCK SPLIT
Posted On Thursday, July 17, 2025
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Thursday, July 17, 2025
NKGen Biotech and HekaBio Enter Strategic Partnership to Bring Novel NK Cell Therapy to Japan
Posted On Thursday, July 17, 2025
Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025
Posted On Thursday, July 17, 2025
Oncotelic Therapeutics Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients
Posted On Thursday, July 17, 2025
SPR to Feature Five Abstracts on SPRINT® PNS at ASPN 2025
Posted On Thursday, July 17, 2025
Tevogen Signs Letter of Intent for New In-House Cell Therapy Manufacturing Facility
Posted On Thursday, July 17, 2025
Creative Medical Technology Holdings Receives Notice of Allowance for the Prevention and/or Treatment of Type 1 Diabetes Using Modulated Immune Cells
Posted On Thursday, July 17, 2025
Adventure Awaits: Make-A-Wish® Central and Northern Florida Makes Jeremy’s Dream Come True with a Thrilling Mexican Sport Fishing Adventure
Posted On Thursday, July 17, 2025
Actuate Therapeutics Advances Clinical Program in Ewing Sarcoma After Positive Phase 1 Trial Demonstrates Complete and Partial Responses in Difficult-to-Treat Pediatric Sarcomas
Posted On Thursday, July 17, 2025
Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025
Posted On Thursday, July 17, 2025
Vor Bio Appoints Qing Zuraw, M.D. as Chief Development Officer
Posted On Thursday, July 17, 2025
Moleculin Engages Industry Veteran Adriano Treve to Explore Accelerated Strategic Partnerships
Posted On Thursday, July 17, 2025
60 Degrees Pharmaceuticals and Tulane University Sign Research Agreement to Study Tafenoquine Against Lyme and Bartonella Bacteria
Posted On Thursday, July 17, 2025

1
2
3
4
5
6
7
8
9
…
Next page
Last page

Print